Neurocrine Bioscience buy Royal Bank of Canada
Start price
06.05.25
/
50%
€105.90
Target price
06.05.26
€128.38
Performance (%)
6.23%
Price
13.08.25
€112.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.23%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.180% | 2.180% |
| iShares Core DAX® | 1.043% | -0.149% |
| iShares Nasdaq 100 | 1.920% | 4.604% |
| iShares Nikkei 225® | 4.840% | 8.328% |
| iShares S&P 500 | 1.567% | 3.310% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Royal Bank of Canada from $137.00 to $145.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
0.04%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
3.35%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
34.92%
13.08.25
13.08.25